<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Induced pluripotent stem cells (iPS) in cellular replacement therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Induced pluripotent stem cells (iPS) in cellular replacement therapy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Induced pluripotent stem cells (iPS) in cellular replacement therapy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Principle of use of induced pluripotent stem cells (iPS) in cellular replacement therapy. Patient cells, ie skin fibroblasts, can be obtained and reprogrammed to pluripotency ex vivo, generating iPS. These iPS can subsequently be differentiated to specific cell types which can be used for autologous transplantation. In monogenic diseases, it may be possible to correct the disease gene in iPS before transplantation.</div><div id="graphicVersion">Graphic 51751 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
